1. Home
  2. VLY vs PCVX Comparison

VLY vs PCVX Comparison

Compare VLY & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

HOLD

Current Price

$13.66

Market Cap

7.3B

Sector

Finance

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$54.99

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLY
PCVX
Founded
1927
2013
Country
United States
United States
Employees
3675
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VLY
PCVX
Price
$13.66
$54.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
4
Target Price
$14.65
$88.25
AVG Volume (30 Days)
6.0M
963.3K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.58
N/A
Revenue Next Year
$8.51
N/A
P/E Ratio
$13.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.36
$28.09
52 Week High
$14.12
$65.00

Technical Indicators

Market Signals
Indicator
VLY
PCVX
Relative Strength Index (RSI) 60.04 36.93
Support Level $11.61 $52.04
Resistance Level $14.00 $56.04
Average True Range (ATR) 0.38 2.33
MACD -0.01 -0.67
Stochastic Oscillator 56.94 9.42

Price Performance

Historical Comparison
VLY
PCVX

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: